跳至主要内容
临床试验/NCT00958802
NCT00958802已完成早期 1 期

Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies

Taipei Medical University WanFang Hospital2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
6
试验地点
2
主要终点
The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.

研究概览

简要总结

Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). These growth factors appear to play an important role in wound healing and are assumed as promoters of tissue regeneration. Moreover, PRP was used as injectable scaffold seeded with chondrocytes to regenerate cartilage. In their previous study, the investigators concluded that growth factors in PRP can effectively react as a growth factor cocktail to induce human nucleus pulposus proliferation and differentiation, and also promote tissue-engineered nucleus pulposus formation. The investigators also have a hypothesis that PRP can promote tissue-engineered microtia auricular cartilage formation. TGF- ß1 exists in the highest concentration and is more important among all of the growth factors released from PRP. So TGF- ß1 can be used as the core ingredient and the indicator for applying PRP in these studies. The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • microtia patient

排除标准

  • non microtia patient

结局指标

主要结局

The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.

时间窗: 4 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Tissue Engineering Microtia Auricular... | 临床试验